George M Milne Jr Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

George M Milne Jr is Director of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 78,733 shares of AUPH, which is worth approximately $710,958. The most recent transaction as insider was on May 18, 2023, when has been sold 8,733 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 78.7K
0% 3M change
0% 12M change
Total Value Held $710,958

GEORGE M MILNE Jr Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2023
BUY
Exercise of conversion of derivative security
-
8,733 Added 9.98%
78,733 Common Stock
Mar 02 2023
BUY
Open market or private purchase
$178,200 $8.91 p/Share
20,000 Added 22.22%
70,000 Common Stock
Mar 04 2022
BUY
Open market or private purchase
$54,100 $10.82 p/Share
5,000 Added 9.09%
50,000 Common Stock
Mar 05 2021
BUY
Open market or private purchase
$65,000 $13.0 p/Share
5,000 Added 10.0%
45,000 Common Stock

Also insider at

CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Healthcare
Director
AMLX
Amylyx Pharmaceuticals, Inc. Healthcare
GMM

George M Milne Jr

Director
Wilmington, MA

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH